MUC13 drives cancer aggressiveness and metastasis through the YAP1-dependent pathway is a research paper published in Life Science Alliance (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: R01CA204552, R01CA210192, R01CA2060696
UT | Health Science Center, University of Tennessee
Grant: E070116019, E070116036
UT | Health Science Center, University of Tennessee
Grant: R16GM146696
Cancer Prevention and Research Institute of Texas
Grant: RP210180, RP230419
NCI NIH HHS
Grant: R01 CA204552
NCI NIH HHS
Grant: R01 CA210192
NCI NIH HHS
Grant: R01 CA206069
National Institutes of Health
Grant: 5R01CA204552-03
MUC13 Mucin in Colorectal Cancer Health Disparity
National Institutes of Health
Grant: 7R01CA210192-05
Targeted Nanotherapy for Pancreatic Cancer
National Institutes of Health
Grant: 1R16GM146696-01
Role of lncRNA UCA1 in anoikis resistantce and colorectal cancer metastasis
National Institutes of Health
Grant: 1R01CA206069-01A1
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
University of Texas Rio Grande Valley
Fields of Study
MeSH Terms
Keywords